- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Biogen Pharmachem Industries Limited has announced a board meeting on which it approved the audited financial results for the year ended March 31, 2025. The company reported a net loss of Rs. 29.27 lakh for the year compared to a profit of Rs. 193.07 lakh the previous year. Revenue from operations stood at Rs. 238.15 lakh, with total expenses significantly higher at Rs. 113.11 lakh versus Rs. 45.08 lakh previously. The auditor issued an unmodified opinion, confirming the results present a fair view of the company’s financial position. Cash flow from operations was negative at Rs. 109.10 lakh, while financing activities provided Rs. 3570.00 lakh primarily from share issues, highlighting efforts to strengthen liquidity. Equity stands strong at Rs. 92.93 Cr, supporting future business continuity.